A human SARS-CoV neutralizing antibody against epitope on S2 protein
- 31 May 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 333 (1) , 186-193
- https://doi.org/10.1016/j.bbrc.2005.05.089
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome CoronavirusJournal of Virology, 2005
- The Ataxia Telangiectasia-Mutated and Rad3-Related Protein Is Dispensable for Retroviral IntegrationJournal of Virology, 2005
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blotClinical Immunology, 2004
- Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomainBiochemical and Biophysical Research Communications, 2004
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004
- Identification of an Antigenic Determinant on the S2 Domain of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Capable of Inducing Neutralizing AntibodiesJournal of Virology, 2004
- Synthetic Peptide Studies on the Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Glycoprotein: Perspective for SARS Vaccine DevelopmentClinical Chemistry, 2004
- SARS: What have we learned?Nature, 2003
- Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides 1 1Edited by I. A. WilsonJournal of Molecular Biology, 2000